DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Visp

Topstories

The Rise of HPAPI Molecules

10.09.2020 -

For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.

News

Lonza and Clovis Open New Monoplant for Ovarian Cancer Drug

04.10.2018 - Lonza and Clovis Oncology have opened a new, dedicated production train for Rubraca (rucaparib), at Lonza’s Visp site in Switzerland. Rubraca is Clovis’ US- and EU-approved drug...

News

Switzerland's Lonza to Cut 500 Jobs

31.10.2012 - Swiss drugs industry supplier Lonza plans to cut 500 jobs, including 400 at its main plant in Visp, to improve profitability as it grapples with price pressures, a strong Swiss...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.